Cargando…

Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes

BACKGROUND: Hashimoto’s disease has reportedly been associated with stroke; however, cerebrovascular morphology and clinical course remain poorly documented. The present study aimed to determine the angiographic features and clinical outcomes of intracranial arterial stenosis (IAS) associated with H...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamano, Eika, Nishimura, Masaki, Mori, Hisae, Satow, Tetsu, Takahashi, Jun C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490896/
https://www.ncbi.nlm.nih.gov/pubmed/32928146
http://dx.doi.org/10.1186/s12883-020-01923-w
_version_ 1783582115340746752
author Hamano, Eika
Nishimura, Masaki
Mori, Hisae
Satow, Tetsu
Takahashi, Jun C.
author_facet Hamano, Eika
Nishimura, Masaki
Mori, Hisae
Satow, Tetsu
Takahashi, Jun C.
author_sort Hamano, Eika
collection PubMed
description BACKGROUND: Hashimoto’s disease has reportedly been associated with stroke; however, cerebrovascular morphology and clinical course remain poorly documented. The present study aimed to determine the angiographic features and clinical outcomes of intracranial arterial stenosis (IAS) associated with Hashimoto’s disease in a retrospective cohort. METHODS: Overall, 107 adult patients with IAS were screened for anti-thyroid antibodies; of these, 26 patients tested positive. The 42 affected hemispheres were classified into subgroups according to the steno-occlusion site and the development of abnormal collateral (moyamoya) vessels. These subgroups were dichotomized into moyamoya vessels positive (MM type) and negative (non-MM type). The initial presentation, IAS progression, and vascular events during the follow-up period were compared. RESULTS: The following sites of stenosis were identified: the bifurcation of the internal carotid artery in 11 (26.2%), M1 or A1 in 29 (69.0%), and more distal (M2-M4/A2-A4) in 2 (4.8%) hemispheres. Further, 17 hemispheres were categorized into the MM type and 25 were classified into the non-MM type. During the follow-up period (mean 2.5 years), IAS progression was identified in 8 (32%) hemispheres of the non-MM type and 0 (0%) hemispheres of the MM type (p = 0.041). Ischemic attacks occurred in 5 (20.0%) hemispheres of the non-MM type (4.6%/year) and 0 hemispheres of the MM type (p = 0.08). Further, 4 (23.5%) hemispheres of the MM type experienced intracerebral hemorrhage, whereas none of the non-MM type hemorrhaged (p = 0.012). CONCLUSIONS: Hashimoto’s disease-associated IAS exhibits various angiographic morphologies, resulting in different clinical presentations. Screening for anti-thyroid antibodies and careful management based on vascular morphology appears important in adults with IAS.
format Online
Article
Text
id pubmed-7490896
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74908962020-09-16 Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes Hamano, Eika Nishimura, Masaki Mori, Hisae Satow, Tetsu Takahashi, Jun C. BMC Neurol Research Article BACKGROUND: Hashimoto’s disease has reportedly been associated with stroke; however, cerebrovascular morphology and clinical course remain poorly documented. The present study aimed to determine the angiographic features and clinical outcomes of intracranial arterial stenosis (IAS) associated with Hashimoto’s disease in a retrospective cohort. METHODS: Overall, 107 adult patients with IAS were screened for anti-thyroid antibodies; of these, 26 patients tested positive. The 42 affected hemispheres were classified into subgroups according to the steno-occlusion site and the development of abnormal collateral (moyamoya) vessels. These subgroups were dichotomized into moyamoya vessels positive (MM type) and negative (non-MM type). The initial presentation, IAS progression, and vascular events during the follow-up period were compared. RESULTS: The following sites of stenosis were identified: the bifurcation of the internal carotid artery in 11 (26.2%), M1 or A1 in 29 (69.0%), and more distal (M2-M4/A2-A4) in 2 (4.8%) hemispheres. Further, 17 hemispheres were categorized into the MM type and 25 were classified into the non-MM type. During the follow-up period (mean 2.5 years), IAS progression was identified in 8 (32%) hemispheres of the non-MM type and 0 (0%) hemispheres of the MM type (p = 0.041). Ischemic attacks occurred in 5 (20.0%) hemispheres of the non-MM type (4.6%/year) and 0 hemispheres of the MM type (p = 0.08). Further, 4 (23.5%) hemispheres of the MM type experienced intracerebral hemorrhage, whereas none of the non-MM type hemorrhaged (p = 0.012). CONCLUSIONS: Hashimoto’s disease-associated IAS exhibits various angiographic morphologies, resulting in different clinical presentations. Screening for anti-thyroid antibodies and careful management based on vascular morphology appears important in adults with IAS. BioMed Central 2020-09-14 /pmc/articles/PMC7490896/ /pubmed/32928146 http://dx.doi.org/10.1186/s12883-020-01923-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Hamano, Eika
Nishimura, Masaki
Mori, Hisae
Satow, Tetsu
Takahashi, Jun C.
Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes
title Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes
title_full Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes
title_fullStr Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes
title_full_unstemmed Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes
title_short Intracranial arterial stenosis associated with Hashimoto’s disease: angiographic features and clinical outcomes
title_sort intracranial arterial stenosis associated with hashimoto’s disease: angiographic features and clinical outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490896/
https://www.ncbi.nlm.nih.gov/pubmed/32928146
http://dx.doi.org/10.1186/s12883-020-01923-w
work_keys_str_mv AT hamanoeika intracranialarterialstenosisassociatedwithhashimotosdiseaseangiographicfeaturesandclinicaloutcomes
AT nishimuramasaki intracranialarterialstenosisassociatedwithhashimotosdiseaseangiographicfeaturesandclinicaloutcomes
AT morihisae intracranialarterialstenosisassociatedwithhashimotosdiseaseangiographicfeaturesandclinicaloutcomes
AT satowtetsu intracranialarterialstenosisassociatedwithhashimotosdiseaseangiographicfeaturesandclinicaloutcomes
AT takahashijunc intracranialarterialstenosisassociatedwithhashimotosdiseaseangiographicfeaturesandclinicaloutcomes